CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 18 filers reported holding CLEVELAND BIOLABS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 51 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 51 | +50.0% | 0.00% | – |
| Q4 2020 | $0 | – | 34 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 34 | -92.6% | 0.00% | – |
| Q2 2020 | $1,000 | – | 457 | +1328.1% | 0.00% | – |
| Q1 2020 | $0 | – | 32 | -73.6% | 0.00% | – |
| Q3 2019 | $0 | – | 121 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 121 | +163.0% | 0.00% | – |
| Q1 2019 | $0 | – | 46 | -4.2% | 0.00% | – |
| Q4 2018 | $0 | – | 48 | -76.0% | 0.00% | – |
| Q3 2018 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 200 | +33.3% | 0.00% | – |
| Q1 2018 | $0 | – | 150 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 150 | -66.7% | 0.00% | – |
| Q3 2017 | $1,000 | – | 450 | +782.4% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 51 | -90.7% | 0.00% | – |
| Q4 2015 | $2,000 | -33.3% | 551 | -16.0% | 0.00% | – |
| Q3 2015 | $3,000 | +200.0% | 656 | +184.0% | 0.00% | – |
| Q2 2015 | $1,000 | -75.0% | 231 | -78.0% | 0.00% | – |
| Q1 2015 | $4,000 | – | 1,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 320,053 | $1,104,000 | 0.04% |
| Renaissance Technologies | 165,651 | $571,000 | 0.00% |
| VANGUARD GROUP INC | 52,592 | $181,000 | 0.00% |
| UBS Group AG | 4,812 | $17,000 | 0.00% |
| IFP Advisors, Inc | 150 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 290 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 100 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 15,000 | $52,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |